Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions		Sep. 30, 2019	Dec. 31, 2018
ASSETS:
Cash and cash equivalents		$ 24.7	$ 25.7
Restricted cash and cash equivalents		329.8	303.6
Restricted securities available for sale	[1]	59.8	58.6
Loans receivable		7,072.8	6,225.2
Allowance for credit losses		(509.1)	(461.9)
Loans receivable, net		6,563.7	5,763.3
Property and equipment, net		58.5	40.2
Income taxes receivable		10.8	7.9
Other assets		23.7	38.1
Total Assets		7,071.0	6,237.4
Liabilities:
Accounts payable and accrued liabilities		184.6	186.4
Revolving secured line of credit		52.2	171.9
Secured financing		3,228.3	3,092.7
Senior notes		940.2	544.4
Mortgage note	[2]	11.5	11.9
Deferred income taxes, net		271.2	236.7
Income taxes payable		0.2	2.5
Total Liabilities		4,688.2	4,246.5
Commitments and Contingencies - See Note 15
Shareholders' Equity:
Preferred stock, $0.01 par value, 1,000,000 shares authorized, none issued		0.0	0.0
Common stock, $0.01 par value, 80,000,000 shares authorized, 18,796,770 and 18,972,558 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively		0.2	0.2
Paid-in capital		155.7	154.9
Retained earnings		2,226.0	1,836.1
Accumulated other comprehensive income (loss)		0.9	(0.3)
Total Shareholders' Equity		2,382.8	1,990.9
Total Liabilities and Shareholders' Equity		$ 7,071.0	$ 6,237.4

[1] Measured at fair value on a recurring basis.

[2] Measured at amortized cost with fair value disclosed.